On January 27, 2026, the Department of Science and Technology of Guangdong Province officially announced the 2025 provincial engineering technology research center accreditation list. The United Bio-Technology (Hengqin) Co., Ltd. successfully obtained approval to establish the "Guangdong Endocrine and Metabolic Drug Engineering Technology Research Center". This approval reflects the company's deep cultivation and focused innovation in the endocrine and metabolic drug field, and also represents high recognition of its technological R&D capabilities and industrial transformation strength.